South Jersey clinic using intestinal ultrasound as an alternative for people with inflammatory bowel disease
A device used in South Jersey is a game-changer for people with inflammatory bowel disease as an alternative to invasive ...
Texas Music Project's Song of Hope gives pediatric patients a voice through music therapy
"It really opened my eyes that we really aren't alone," Chloee Rae said about the impact of her music video produced by the ...
Researchers identify key driver of fibrosis in Crohn's disease
Crohn's disease, a type of chronic inflammatory bowel disease (IBD), often causes scar-like tissue to build up in the ...
Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?
We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look ...
Teva, Sanofi say bowel disease drug met primary targets (Dec 17)
Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping ...
Managed Healthcare Executive1d
FDA Approves Seventh Stelara Biosimilar, Steqeyma
The FDA has approved Celltrion’s Stelara biosimilar Steqeyma (CT-P43), for adult and pediatric patients with plaque psoriasis ...
Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial
The companies said Tuesday that patients with ulcerative colitis who were treated with duvakitug achieved a higher rate of clinical remission compared with a placebo group. A group of patients with ...
Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's
Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...
Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment
Teva Pharmaceuticals' shares soared and Sanofi's stock moved higher following positive results from the latest trial of their jointly developed treatment for inflammatory bowel disease.
BioPharma Dive1d
Sanofi, Teva say study results show gut disease drug could be ‘best in class’
Phase 2 results in inflammatory bowel disease hinted the therapy could be more potent than similar medicines from Merck and ...
FierceBiotech1d
Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in midstage trial
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...